The Business Research Company’s Prosthetic Heart Valve Devices And Equipment Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022 - 2026
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
First Patients Enrolled in the Merit WRAPSODY AV Access Efficacy Pivotal Study
Merit Medical Systems, Inc.March 11, 2021 GMT
SOUTH JORDAN, Utah, March 11, 2021 (GLOBE NEWSWIRE) Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today the enrollment of the first patients in its Wrapsody ArterioVenous (AV) Access Efficacy Pivotal Study (the “WAVE Study”) of the WRAPSODY™ Endovascular Stent Graft, an investigational device being studied for the treatment of stenosis or occlusion within dialysis outflow circuits. Jeffrey Hoggard, MD at RAC Surgery Center LLC, Raleigh, NC successfully enrolled the first two subjects with venous outflow peripheral lesions.